Hyperphosphatemia in dialysis patients: is there a role for focused counseling?

Background: Elevated serum phosphorus (P) and calcium-P product (CaXP) are associated with cardiac mortality in dialysis patients. A CaXP <55 is considered acceptable by most authorities. Because nutrition practices can modulate CaXP, we designed a survey to study the impact of the patients' levels of education and disease awareness on their CaXP.